ONE FRANKLIN PARKWAY,
SAN MATEO , CA, 94403-1906
SAN MATEO , CA, 94403-1906
Summary
The fund seeks capital appreciation by investing in small-size companies in the United States.
The investment process is designed to highlight biotechnology companies and discovery research firms.
The investment team considers a biotechnology company or discovery research firm is one that has at least 50% of its earnings derived from biotechnology activities, or at least 50% of its assets devoted to such activities, based o More
Link
Directors
Jul 12, 2023- Gregory E. Johnson
- Larry D. Thompson
- Edith E. Holiday
- J. Michael Luttig
- Rupert H. Johnson, Jr.
- Mary C. Choksi
- Valerie M. Williams
- Harris J. Ashton
- Terrence J. Checki
Chief Compliance Officer
- Ted P. Becker
Fund Manager(s)
Price
- 52-Week High/Low
- $160.08 - $105.44
- Turnover
- 14.6%
- Expense Ratio
- 0.82%
Company Name |
Holding |
| Amgen, Inc. | 8.19 % |
| Regeneron Pharmaceuticals, Inc. | 7.14 % |
| Vertex Pharmaceuticals, Inc. | 6.04 % |
| Insmed, Inc. | 3.76 % |
| Ascendis Pharma A/S | 3.61 % |
| Gilead Sciences, Inc. | 3.27 % |
| Intra-Cellular Therapies, Inc. | 2.97 % |
| Institutional Fiduciary Trust Money Market Portfolio | 2.97 % |
| Biogen, Inc. | 2.93 % |
| AstraZeneca plc | 2.83 % |
| More | 2.83 % |
Documents
Performance
YTD
-
3 Year
-4.78%
5 Year
0.56%
Best
69.21%
2013
Worst
-27.86%
2021
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 11.6% | 0.9% | -9.2% | -17.6% | -12.4% | 19.5% | 0.1% | 12.9% | -24.5% |
| Q2 | - | -4.2% | 1.9% | -11.8% | 15.8% | 29.1% | 3.6% | 7.6% | 2.1% | 1.9% |
| Q3 | - | - | -1.7% | 1.9% | -17.5% | -8.8% | -14.2% | 4.3% | 9.3% | 14.6% |
| Q4 | - | - | 19.5% | 6.9% | -8.5% | 10.9% | 16.5% | -21.3% | -6.5% | -5.8% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 4.9% | 8% | -1.5% | -9.6% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 6% | 19% | -13% | -28% | 14% | 24% | -16% | 19% | -17% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| FTDZX | - | 6% | 19% | -13% | -28% | 14% | 24% | -16% | 19% | -17% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 6% | 19% | 8% | -55% | -2% | -5% | -9% | -0% | -26% |